One approach to addressing these challenges is the integration of digital care solutions, which can offer greater protection for older patients. By utilizing remote monitoring technologies, healthcare providers can track vital health metrics in real-time, allowing for prompt adjustments to treatment plans as needed. These tools can also facilitate regular communication between patients and providers, ensuring that any concerns or side effects are quickly addressed, thus enhancing the overall effectiveness and safety of the treatment.
應對這些挑戰的一種方法是整合數位護理解決方案，這可以為老年患者提供更大的保護。透過利用遠端監控技術，醫療保健提供者可以即時追蹤重要的健康指標，從而根據需要及時調整治療計劃。這些工具還可以促進患者和提供者之間的定期溝通，確保快速解決任何問題或副作用，從而提高治療的整體有效性和安全性。

With connected health devices that collect patient-generated data on a daily basis, care teams can have more insight into health risks that older patients are more susceptible to when taking GLP-1s:
借助每天收集患者產生數據的互聯健康設備，護理團隊可以更深入地了解老年患者在服用 GLP-1 時更容易遭受的健康風險：

• Sarcopenia: About a quarter of GLP-1 agonist weight loss results from the loss of muscle and bone, both of which are necessary to protect us as we get older. Although some muscle loss is a natural part of aging, it accelerates while on GLP-1s. Weakened muscles can make everyday activities difficult, and can lead to falls or other injuries. Low muscle mass is also associated with poor health outcomes — researchers found that individuals with diabetes and low muscle mass have a higher risk of mortality from cardiovascular disease.
  肌少症：大約四分之一的 GLP-1 激動劑體重減輕是由於肌肉和骨骼的損失造成的，隨著年齡的增長，肌肉和骨骼對於保護我們是必要的。雖然有些肌肉流失是老化的自然現象，但服用 GLP-1 時肌肉流失會加速。肌肉無力會使日常活動變得困難，並可能導致跌倒或其他傷害。低肌肉質量也與不良的健康結果有關——研究人員發現，患有糖尿病和低肌肉質量的人死於心血管疾病的風險更高。
• Malnutrition: Although suppression of appetite is a key mechanism of GLP-1 medications, too much appetite control can be dangerous, particularly in older adults who are more prone to having reduced food intake. Studies have found diminished appetite is a common problem for older adults — both those living at home and at care facilities. Early insight into a patient’s weight and body composition can help care teams intervene earlier to promote better appetite and food intake. Low muscle mass further compounds the risk of malnutrition. A study led by the Center for Translational Research in Aging & Longevity at Texas A&M University found that current care approaches for malnutrition often don’t account for the importance of muscle mass restoration. Researchers recognized the challenge of measuring body composition in clinical practice, noting “the need to raise awareness of the importance of screening and managing ‘at risk’ patients so it becomes routine is imperative for change to occur.”
  營養不良：雖然抑制食慾是 GLP-1 藥物的關鍵機制，但過多的食慾控制可能是危險的，特別是對於更容易減少食物攝取的老年人。研究發現，食慾減退是老年人的常見問題——無論是住在家裡還是住在護理機構的老年人。及早了解患者的體重和身體組成可以幫助護理團隊儘早進行幹預，以促進更好的食慾和食物攝取。肌肉質量低進一步加劇了營養不良的風險。德州農工大學老化與長壽轉化研究中心領導的一項研究發現，目前針對營養不良的照護方法通常沒有考慮到肌肉質量恢復的重要性。研究人員認識到在臨床實踐中測量身體組成的挑戰，並指出“需要提高對篩檢和管理‘高風險’患者重要性的認識，使其成為常規，這對於發生改變至關重要。”
• Gastrointestinal side effects: Severe gastrointestinal side effects from these medications can result in dehydration, which may increase the likelihood of falls. The most commonly reported side effects include gastrointestinal issues such as vomiting and nausea. When dehydration occurs, individuals are more prone to dizziness or fainting, raising the risk of falling. For older adults a fall could be the start of serious health issues and can even lead to a long-term disability. It is essential to ensure that older adults taking weight loss medications can monitor their hydration levels on a daily basis.
  胃腸道副作用：這些藥物引起的嚴重胃腸道副作用可能導致脫水，從而增加跌倒的可能性。最常見的副作用包括嘔吐和噁心等胃腸道問題。當脫水發生時，個人更容易頭暈或昏厥，從而增加跌倒的風險。對於老年人來說，跌倒可能是嚴重健康問題的開始，甚至可能導致長期殘疾。確保服用減肥藥物的長者能夠每天監測自己的水分水平至關重要。